Cefazolin and Cefoxitin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Cefoxitin (cefoxitin sodium). Common drug interactions include abdominal pain among females and cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Cefoxitin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Cefoxitin?

Cefoxitin has active ingredients of cefoxitin sodium. eHealthMe is studying from 611 Cefoxitin users. Check the latest studies of Cefoxitin.



On Jul, 10, 2026

21 people who take Cefazolin and Cefoxitin together, and have interactions are studied.

Cefazolin and Cefoxitin drug interactions.

What are the common drug interactions of Cefazolin and Cefoxitin, by gender? *:

female:

  1. Abdominal pain
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Colitis pseudomembranous (antibiotic-associated diarrhoea)
  4. Diarrhoea
  5. Endocarditis staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection)
  6. Hepatic steatosis (fatty liver disease)
  7. Hepatitis (inflammation of the liver)
  8. Injury
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Pericardial effusion (fluid around the heart)
  3. Blindness
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cardiac failure
  6. Disease recurrence
  7. Erythema multiforme (a type of hypersensitivity reaction)
  8. Eye disorder
  9. Fungal infection
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Cefazolin and Cefoxitin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cardiomyopathy (weakening of the heart muscle)
  2. Pericardial effusion (fluid around the heart)
  3. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  4. Anxiety
  5. Blindness
  6. Cardiac failure
  7. Erythema multiforme (a type of hypersensitivity reaction)
  8. Escherichia infection (bacterial infection by escherichia coli)
  9. Eye disorder
  10. Fungal infection

10-19:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Endocarditis staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection)
  3. Hepatic steatosis (fatty liver disease)
  4. Hepatitis (inflammation of the liver)
  5. Injury
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nausea (feeling of having an urge to vomit)
  8. Pneumonia
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Renal failure (kidney dysfunction)

20-29:

  1. Leukopenia (less number of white blood cells in blood)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Disease recurrence
  4. Escherichia infection (bacterial infection by escherichia coli)

30-39:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Renal failure (kidney dysfunction)
  3. Renal failure acute (rapid kidney dysfunction)

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain
  2. Colitis pseudomembranous (antibiotic-associated diarrhoea)
  3. Diarrhoea
  4. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  5. Post procedural infection
  6. Procedural pain
  7. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  8. Urethral haemorrhage (urethral bleeding)

What are the existing conditions these people have? *

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 9 people, 42.86%
  2. Pain: 8 people, 38.10%
  3. Stress And Anxiety: 7 people, 33.33%
  4. Fever: 7 people, 33.33%
  5. Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 6 people, 28.57%
  6. Fungaemia (fungi circulate in the blood): 6 people, 28.57%
  7. Pneumonia: 4 people, 19.05%
  8. Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Cefoxitin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin and Cefoxitin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefoxitin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefoxitin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and cefoxitin sodium (the active ingredients of Cefazolin and Cefoxitin, respectively), and Cefazolin and Cefoxitin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: